Guidelines
1,823 entriesSpeciality / institutional guidelines
- CT Imaging ChecklistClick on the image to enlarge. Click here for the pdf . Angels Initiative South Africa _ Stroke Physician CT Imaging Checklist_2024→
- Caesarean SectionThe guidelines recommend management of common obstetric conditions at primary and referral level, based on local experience and evidence-based practice. They are not intended as strict protocols nor as standard operating procedures, but rather as a guide to safe effective management of common obstetric problems. The guidelines should be most useful to interns, medical officers and registrars.→
- Cannot Intubate and Cannot Ventilate (CICV) in a Paralysed Anaesthetised ChildCannot Intubate and Cannot Ventilate (CICV) in a Paralysed Anaesthetised Child Aged 1 - 8 Years→
- Cardiac Prophylaxis for Invasive ProceduresCardiac prophylaxis for invasive procedures→
- Cardiac TherapyMinoxidil Angiotensin receptor blockers (ARBs) Atorvastatin - high dose (80mg/day) Ezetimibe ATC Code C02DC01 Medicine Minoxidil Indication Severe hypertension not responding to other drugs NEMLC Recommendation Approved Review Indicators n/a Date Ratified 20 September 2007 ATC Code C09CA Medicine Angiotensin receptor blockers (ARBs) Indication Add on therapy in cardiac failur→
- Cardiopulmonary Resuscitation (CPR) in PregnancyThe guidelines recommend management of common obstetric conditions at primary and referral level, based on local experience and evidence-based practice. They are not intended as strict protocols nor as standard operating procedures, but rather as a guide to safe effective management of common obstetric problems. The guidelines should be most useful to interns, medical officers and registrars.→
- Cardiovascular Risk and the Management of DyslipidaemiaCardiovascular Risk and the Management of Dyslipidaemia in Patients with Type 2 Diabetes Mellitus→
- Care Pathway for People with Diabetic Foot ProblemsCare Pathway for People with Diabetic Foot Problems→
- Care of the HIV-Exposed Infant after BirthHIV Testing and Early Infant Diagnosis Confirmatory Test for HIV Infant Prophylaxis Other Routine Care HIV Testing and Early Infant Diagnosis 3 - 6 Days Follow-up results of birth HIV-PCR and manage accordingly. Any HIV positive neonate should be discussed/referred to a clinician experienced in managing an HIVpositive neonate. ART should be initiated even if the infants weighs less than 2,5 kg. 6→
- Care of the Mother after BirthTesting for HIV Antiretrovirals VL Monitoring and Management Screening for TB and other OI's Testing for HIV 6 days Retest the HIV negative mother if she was not retested in labour 10 weeks Retest every HIV-negative mother at the 10-week visit (~three months postpartum), the six-month visit , and every three months whilst breastfeeding. Remember to offer partner testing. If no longer→
- Care of the Pregnant Adolescent Living with HIVPregnant adolescents are a vulnerable group that have psycho-social stressors and medical risks that may result poor health outcomes 14 Click on image to enlarge. The pregnant adolescent requires non-judgmental, confidential, and quality youth friendly SRH services that are sensitive to the challenges and stressors experienced by adolescents. This care should include: For ART Regimens applicable→
- Care of the Terminally Ill PatientThis booklet is intended as a practical guide to patient care for registrars, medical officers, interns and medical students attached to the gynaecology units at the University of the Witwatersrand Academic Hospitals. Anyone can use it.→
- Categorisation of Intensive Care UnitsLevel 1 ICU (High care) Level 2 ICU Level 3 ICU There is no universally accepted method of classifying intensive care units. For the purposes of classifying the services offered, and resources required by different levels of ICUs, a system proposed by the (then) World Federation of Societies of Intensive and Critical Care Medicine has been modified for local circumstances 6 : Level 1 ICU (H→
- Caudal BlockInformation for Parents→
- Caustic IngestionIntroduction Background Important details on history Important details on examination Emergency management Referral guidance Parental counselling List of typical caustic agents SETTING Primary and Secondary Healthcare Institutions in the Western Cape which refer to Red Cross War Memorial Children’s Hospital (RCWMCH) FOR STAFF Primary and Secondary Doctors and Nurses who refer patients to&nbs→
- Cavernous Sinus ThrombophlebitisInfection Cavernous sinus thrombophlebitis Brief outline/clinical setting Septic thrombosis of the cavernous sinus, usually caused by nasal furuncles or bacterial sinusitis. Initial symptoms of cavernous sinus thrombosis are progressively severe headache or facial pain, usually unilateral and localized to retro-orbital and frontal regions. High fever is common. Later, ophthalmoplegia (typically t→
- CellulitisInfection Cellulitis Brief outline/clinical setting Acute superficial infection involving dermis and subcutaneous tissue, most commonly affects the lower extremities. It causes local signs of inflammation, such as warmth, erythema, pain, lymphangitis, and frequently systemic upset with fever and raised white blood cell count. Aetiologies/organisms Streptococci (e.g. S. pyogenes , group B streptoc→
- Central Line Associated Blood Stream Infections (CLABSI) and Catheter Associated Urinary Tract Infection (CAUTI)CAUTI & CLABSI→
- Cerebral AbscessInfection Cerebral abscess Brief outline/clinical setting May be as a result of contiguous spread of organisms, haematogenous spread, or iatrogenic Discuss with Neurology/Neurosurgery for aspiration and culture Aetiologies/organisms S.aureus, S.anginosus group, Enterobacterales, other Streptococci, anaerobes, Nocardia spp. Optimal antimicrobial selection 3rd gen cephalosporin (cefotaxime 8-12 g/d→
- Cerebral Arterial Gas EmbolismCerebral Arterial Gas Embolism→
- Cervical CancerThis guideline is intended as a practical guide to patient care for registrars, medical officers, interns and medical students attached to the gynaecology units at the University of the Witwatersrand Academic Hospitals. Anyone can use it.→
- Cervical ScreeningThis booklet is intended as a practical guide to patient care for registrars, medical officers, interns and medical students attached to the gynaecology units at the University of the Witwatersrand Academic Hospitals. Anyone can use it.→
- Changing AntibioticsThis guideline aims to assist healthcare workers with antibiotic prescribing for common clinical syndromes in adult patients in South Africa, utilizing Local and International guidelines, key publications, and expert opinion.→
- Checklist for the Management of Sexual Abuse in ChildrenRainbow Clinic for Abused Children, April 2020→
- Chemical InjuryChemical Injury→
- Chest CompressionsNational Neonatal Resuscitation Guidelines→
- Chest Trauma - BluntBlunt Chest Trauma→
- Chest Trauma - PenetratingPenetrating Chest Trauma→
- Child Abuse vs Trauma (Orofacial Manifestations)And recognising and reporting of suspected cases of abuse→
- Child Contacts: Children Weighing Less Than 25 Kilograms and InfantsTPT should be offered to TPT should be deferred or not offered if the child Management of TPT in children weighing less than 25 kilograms Management of TPT in children living with HIV (irrespective of TB exposure) Management of TPT in TB-exposed newborns (babies born to mothers diagnosed with pre-natal or peripartum TB or with other significant TB exposure) Significant exposure is known (document→
- Chloroquine ToxicityDivision of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences→
- Choice of Insulin and Pump DeviceChoice of Insulin and Pumps Device→
- Choking AlgorithmChoking Algorithm→
- ChorioamnionitisThe guidelines recommend management of common obstetric conditions at primary and referral level, based on local experience and evidence-based practice. They are not intended as strict protocols nor as standard operating procedures, but rather as a guide to safe effective management of common obstetric problems. The guidelines should be most useful to interns, medical officers and registrars.→
- Chronic AsthmaPaediatrics - Chronic Asthma→
- Chronic HypertensionChronic Hypertension→
- Circular 6 March 2025: Supply Constraints with Rifampicin-based combinations for TB treatment - interim therapeutic alternativesThe Primary Healthcare, Adult Hospital-Level, and Pediatric Hospital-Level Standard Treatment Guidelines (STGs) and the Essential Medicines List (EML) currently recommend the use of rifampicin/isoniazid (RH) 150/75 mg and 300/150 mg for the continuation phase of tuberculosis (TB) treatment and TB preventive therapy. However, there is currently an insufficient national supply of RH to meet demand.→
- Circular 01 April 2026: Retraction of Paediatric Abacavir/ Lamivudine/ Dolutegravir (pALD) Fixed Dose Combination TabletThe circular titled Availability of New Antiretroviral Products: Paediatric Abacavir/ Lamivudine/ Dolutegravir (ABC/3TC/DTG) 60 mg/30 mg/5 mg Fixed-Dose Combination Dispersible Tablets (pALD) (Reference: 2026/01/19/EDP/01) was issued on 6 February 2026 to inform provinces, districts, clinical managers, pharmacists, and healthcare workers of the availability of pALD, including its clinical indicat→
- Circular 03 October 2024: Appendix IV Extemporaneous Preparations Morphine ReformulationFollowing the erratum which was circulated to external stakeholders regarding the corrected extemporaneous compounding formula for morphine oral solution on the 21 August 2023 (refer to Circular Number: 2023/08/21/EDP/01), the National Essential Medicines List Committee (NEMLC) reviewed the full guidance and updated the recommendations. The updated recommendations were reviewed with input from pa→
- Circular 04 September 2025: National Essential Medicines List Committee (NEMLC) BulletinAccessing the Latest Documents To get started, you'll need to find the most current versions of the National Health Insurance (NHI) Standard Treatment Guidelines (STGs) and the Essential Medicines List (EML) found on Knowledge Hub elibrary . The best place to find these is on the official NHI webpage . This is the primary source for the latest documents. If you're looking for older or "historic"→
- Circular 06 May 2024: Availability of Insulin Pen SetsCircular: Availability of Insulin Pen Sets The National Department of Health (NDoH) is committed to ensuring equitable access to quality healthcare for diabetic patients through ensuring the availability of safe, effective, and cost-effective medicines, in the appropriate dosage form at the appropriate level of care. In line with this commitment, the recent tender HP06-2024SVP, advertised on 15 J→
- Circular 08 April 2026: Erratum to the Paediatric Hospital Level Standard Treatment Guidelines and Essential Medicine ListPlease note the following updates have been made to the Paediatric Hospital Level Standard Treatment Guidelines (STGs) and Essential Medicine List (EML) - Review Cycle 2025-2029. Chapter 18: Poisoning Annexure 1: Amoxicillin/clavulanic acid – Weight Band Dosing Table Click here to access pdf . →
- Circular 09 March 2026: Cisatracurium Injection Supply Constraints and Proposed Therapeutic AlternativesThe Standard Treatment Guidelines (STGs) and Essential Medicines List (EML) currently recommends cisatracurium as a non-depolarising muscle relaxant (NDMR) in patients with renal or liver impairment. The contracted supplier of cisatracurium, Accord Healthcare (Pty) Ltd, is however currently unable to meet their contract obligation resulting in supply constraints. Accord Healthcare (Pty) Ltd has i→
- Circular 12 December 2025: Notice - Flucytosine 500mg Tablet Stock Supply and Implications for the Treatment of Cryptococcal MeningitisThe 2024 Adult Hospital Level and 2023 Paediatric Hospital Level editions of the Standard Treatment Guidelines (STGs) and Essential Medicines List (EML) currently recommend oral flucytosine as a critical part of the induction phase treatment regimen of cryptococcal meningitis (CCM) used in combination with intravenous amphotericin B and oral fluconazole. Recently, the supply of oral flucytosine h→
- Circular 12 December 2025: Notice - Updates to the Primary Healthcare and Adult Hospital Level STGs and EMLPlease note the updates (in the document below), made to the 2024 PHC and AHL combined editions of the STGs and EML: Click here to access the pdf .→
- Circular 13 April 2026: Biperiden 5mg per ml Injection 1ml - Stock Supply Shortage and the Proposed Therapeutic AlternativeThe Adult Hospital Level (AHL), Paediatric Hospital Level (PHL), and Primary Healthcare (PHC) Standard Treatment Guidelines (STGs) and Essential Medicines List (EML) 1,2,3 currently recommend biperiden injection as a treatment option for acute dystonic reactions. The contracted supplier of biperiden injection, Pharmaco Distribution (Pty) Ltd, is experiencing supply constraints with this product.→
- Circular 14 February 2025: Morphine for injection containing preservative - caution regarding routes of administrationThe Adult Hospital-Level and Pediatric Hospital-Level Standard Treatment Guidelines (STGs) and the Essential Medicines List (EML) recommend the use of morphine injection for various clinical indications. Currently, 10 mg/mL and 15 mg/mL morphine injections are available through a national contract with Pharma-Q and Unimed Healthcare. However, there are important differences in the excipients used→
- Circular 14 January 2026: Notice - Zinc PicolinateProvinces and Healthcare Facilities are informed of the media statement released by the South African Health Products Regulatory Authority on 08 January 2026 regarding selenium and zinc picolinate-containing products: Warning: Selenium and zinc picolinate-containing products for children https://www.sahpra.org.za/news-and-updates/warning-selenium-and-zinc-picolinate-containing-products-for-childr→
- Circular 14 October 2024: Ethionamide Availability and Therapeutic AlternativeThe Paediatric Hospital Level Standard Treatment Guidelines (STGs) and Essential Medicines List (EML) recommends the use of ethionamide in the regimens for the management of miliary tuberculosis (TB), and TB meningitis (TBM). The available stock of ethionamide expired on 1 October 2024, and currently there is no other stock in the country to service this clinical need. The sourcing of ethionamide→
- Circular 15 April 2024: PHC/Adult Hospital Expert Review Committee: Evidence Summary Isoniazid Preventive Therapy in PregnancyTuberculosis disease during pregnancy and the post-partum period is associated with adverse maternal, pregnancy, infant outcomes.(1) There is consensus regarding the benefit of treating active tuberculosis disease during pregnancy. Additionally, there is consensus regarding the benefit of isoniazid preventive therapy (IPT) in non-pregnant people living with HIV (PLWHIV) to prevent tuberculosis di→